Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Pathway for Softgel vs Tablet Comparison [Design Issues]

posted by jag009 – NJ, 2018-05-18 18:33 (2607 d 18:41 ago) – Posting: # 18786
Views: 3,259

Hi,

❝ However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Have you read this guidance? FDA

John

Complete thread:

Bioequivalence of IR vs MR tablet heritage 2018-05-05 06:25 [Design Issues]
- Consider 505(b)(2) Pathway bebac_fan 2018-05-05 17:08
  - Pathway for Softgel vs Tablet Comparison Obinoscopy 2018-05-15 19:04
    - Pathway for Softgel vs Tablet Comparisonjag009 2018-05-18 16:33

Admin contact
23,428 posts in 4,929 threads, 1,697 registered users;
98 visitors (0 registered, 98 guests [including 25 identified bots]).
Forum time: 13:14 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory. Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz